Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Drugs and Medicinal Substances

Lomustine

Antineoplastic and Immunomodulating Agents

Lomustine, also known by the abbreviation CCNU, is an alkylating nitrosourea compound used in chemotherapy. It is highly soluble in fat, which lets it cross the blood brain barrier, making it especially useful for treating brain tumors, though it is also used for Hodgkin lymphoma. As a bifunctional alkylating agent it creates cross links between strands of DNA and can inhibit other enzymatic processes needed for cell division. The United States approved lomustine in 1976 for high grade gliomas, and it remains the standard of care for recurrent glioblastoma multiforme in Europe.

Facts
Drug Class
Alkylating nitrosourea chemotherapy compound 1
Mechanism of Action
Forms electrophilic alkylating products that attack nucleophilic sites on DNA and RNA 1
Approved Use
Treats brain tumors and progressive Hodgkin lymphoma 1
First Approved / Isolated Year
1976 1
Significant Risk
Causes delayed, dose-dependent, cumulative myelosuppression 1
Classification
Approval Status
Approved 1
ATC ClassSourced to the subject's own account
L: Antineoplastic and Immunomodulating Agents 2
Route of Administration
Oral 3
Connections

Long-Form Articles

Sources
1. Lomustine (Wikipedia)
  • Lead section
    Lomustine (INN; abbreviated as CCNU; original brand name CeeNU, now marketed as Gleostine) is an alkylating nitrosourea compound used in chemotherapy.
  • Mechanism of action section
    These products are electrophilic, and they attack nucleophilic sites on DNA and RNA to form alkylated products.
  • Medical uses section
    indicated by the FDA for the treatment of patients with brain tumors (primary and metastatic), following any necessary surgery and radiation, as well as for treatment of progressive Hodgkin's lymphoma
  • History section
    Lomustine was approved by the FDA to treat high-grade gliomas in 1976.
  • Safety section
    Lomustine causes myelosupression in a delayed, dose-dependent, and cumulative fashion.
  • Regulatory approval status
View the Source
2. Anatomical Therapeutic Chemical Classification System (Wikipedia)
WikipediaFirst-level anatomical group codes, Code L
Quote, First-level anatomical group codes, Code L
Antineoplastic and immunomodulating agents
View the Source
3. Lomustine (Wikipedia)
WikipediaInfobox drug, routes_of_administration
Quote, Infobox drug, routes_of_administration
Oral (capsules)
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.